Directory · DK
Biotechnology Research in Denmark
A register of firms and the professionals working at them in the Biotechnology Research sector based in Denmark. Browse the public index, then filter or export on Kipplo.
Companies
286 on file
Nordic Bioscience
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research. We support some of the largest pharmaceutical companies in preclinical and clinical research with three decades of experience in biomarker development. With more than 750 peer-reviewed publications, our science-driven approach has been the evolving force behind our decades of success. Through our Nordic ProteinFingerPrint Technology™, we identify fragments of the extracellular matrix (ECM) that are released from affected tissues and develop blood-based biomarker assays to quantify disease activity with the aim of precision medicine. By quantifying tissue remodeling, our biomarkers provide true prognostic and predictive value, as we can select the patients who are most likely to respond to a given treatment and thereby function as surrogate biomarkers for clinical trials. Our biomarker assays not only enable faster drug development but also improve disease outcomes for chronically ill patients by predicting treatment response. Nordic Bioscience is headquartered in Herlev, Denmark, with a high-quality standard laboratory, running clinical trials under Good Clinical Laboratory Practice (GCLP) with accreditation by the College of American Pathologists (CAP), certification by Clinical Laboratory Improvement Amendments (CLIA), and an ISO9001 certificate. Everything in our laboratory supports compliance with FDA 21 CFR Part 11. We employ more than 220 people who are dedicated to improving patient management for a broad range of therapeutic areas, including Cardiology, Dermatology, Gastroenterology, Hepatology, Kidney and Respiratory diseases, Obesity, Oncology, and Rheumatology. Read more about us:
201 to 500 staff
Bioinnovation Institute Bii
Do you have a great research-based idea in planetary health or human health? Are you ready to bring your research out of the lab and into the economy? BioInnovation Institute (BII) offers life science researcher and entrepreneurs access to a vibrant life science community with 3500 square meter of advanced lab and office facilities, business acceleration programs, commercial support, funding opportunities and access to high-level mentoring and networks. We embrace every stage of a life science start-up, so whether the idea of pursuing entrepreneurship has briefly crossed your mind, or you already have a full business plan for your project, there is a place for you at BII. We are a Novo Nordisk Foundation Initiative, and we work for the benefit of human welfare and society.
51 to 200 staff
Evaxion A S
Evaxion A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.
11 to 50 staff
Galecto, Inc
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure and SEED Capital.
11 to 50 staff
Minerva Imaging
Minerva Imaging is a scientifically driven CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
51 to 200 staff
Scanbur
SCANBUR is internationally renowned for its dedication to the medical research industry. For 50+ years SCANBUR has been recognized for supplying products that are innovative and of a superior quality. The advice we can offer reflects our years of experience. As a consequence, our team of employees is highly skilled and experienced professionals. Our concept is not to supply single products, but an individually tailored system of compatible products, services, and training. Since the company was founded SCANBUR has made a special effort to create a close association with manufacturers of high-quality products dedicated to the research industry with awareness of the special needs and quality demands within this area. The protection of both staff and research models is prioritized. SCANBUR has actively participated in equipping many of the most up-to-date research facilities in the world.
51 to 200 staff
21st.Bio
21st.BIO was founded with one simple mission: to make leading industrial scale precision fermentation technology accessible to as many as possible, so companies can successfully take biotech innovations to market at a competitive price. 21st.BIO focuses on developing industrial production technology for proteins and other molecules of interest for food, nutrition, agriculture, biomaterials, and biomining industries. 21st.BIO's founders saw that too often, great bio innovation and molecules fail to translate into commercial success. The innovation is ready, the market is there, but production costs remain too high for the product to go mainstream. Industry insiders call it the 'valley of death', and that's exactly what 21st.BIO intends to bridge. Founded in 2020, 21st.BIO is headquartered in Copenhagen, Denmark, and has a world-class R&D team as well as laboratories in both Copenhagen, Denmark and Davis, California. On a mission to support bio industrial companies globally in upscaling from molecule innovation to large-scale production, 21st.BIO enables its customers to meet market demands, and thereby advance the green transition globally. Established as a fully integrated end-to-end partner, 21st.BIO supports its customers from technical assessment, strain development and optimization, production processes and upscaling, tech transfer to large scale manufacturing and regulatory services. 21st.BIO's fermentation technology is in part licensed from Novonesis, who have developed and perfected their platform over several decades.
51 to 200 staff
Chromologics
Chromologics is a Danish biotech start-up responding to the strong market pull for novel natural food colorants. We develop fungal fermentation solutions for the production of natural pigments. Our proprietary production process allows not only for a more sustainable production than existing solutions, but is also cost-competitive. Our pigments are produced by a non-GMO fungus, which makes them compliant with the dietary requirements of broad consumer bases such as kosher, halal, and vegan diets.
11 to 50 staff
Eurofins Steins Laboratorium
Eurofins Steins is part of the world leading food and feed testing laboratory group Eurofins Scientific. We establish the safety, composition, authenticity, origin, traceability and purity of food.
201 to 500 staff
Bioxpedia A S
BioXpedia A/S is a contract service organisation. We are passionate about helping the research community with laboratory analyses, and with biostatistical services. We want to facilitate and accelerate research projects from idea to validated data. BioXpedia offers high-throughput sample preparation and multiomic screening and analysis to researchers worldwide. We provide rapid, multiplex, and low-volume technologies for efficient use of your valuable samples. BioXpedia provides preclinical laboratory analyses, biostatistical service and scientific support to help research units at hospitals, universities, biotech, and pharmaceutical companies that in identifying new clinically useful biomarkers and drug targets. Services: • Protein biomarker analyses • Small molecules LC-MS/MS • DNA/RNA/miRNA extraction and analyses • Custom Cell Culture workflows/ in-vitro screening • Biostatistics - standard and tailored Technologies: • Proximity Extension Assay, Olink Proteomics, Olink Explore • LC-MS/MS, Sciex QTRAP 4500 • Immunoassays, Meso Scale Discovery and ELISA • nCounter digital barcode technology, NanoString • Multiplex qPCR, Fluidigm Biomark HD • Digital PCR, QIAcuity Get in touch to explore how we can assist you. Email: info@bioxpedia.com Phone:+45 70 23 10 01
11 to 50 staff
Ramcon
Ramcon's mission is to combine global products and expertise with local knowledge in the Nordic countries. Ramcon is a focused Nordic distributor. We strive to maintain a high, professional level. The company consists of competent and well-educated employees at offices in Sweden and Denmark. Our strength is knowing our customers' needs as well as a vast knowledge of the Industrial, Medical, Chemical and Life Science market in the Nordic countries. Ramcon constantly strives to be an organisation characterised by a positive social atmosphere. We value integrity and respect for colleagues, customers and partners very highly. We invest in people as the primary marketing resource and offer a high level of service and support to our customers. It is the company's strategy to build good and lasting customer relations. For more information or career opportunities please contact; ramcon@ramcon.dk or ramcon@ramcon.se.
51 to 200 staff
Shimadzu Danmark
Velkommen til Shimadzu Danmark - din samarbejdspartner inden for analytisk Instrumentering! På vores hjemmeside træder du ind i en verden af banebrydende teknologi og innovative løsninger. Vores brede spektrum af analyseinstrumenter er essentielle for forskning, udvikling og kvalitetskontrol i en række markedssegmenter, herunder fødevarer, pharma, miljø, kemisk, og meget mere. Fra avanceret gaskromatografi og væskekromatografi til ultrahurtig massespektrometri og Life Science laboratorieinstrumenter - vores sortiment er skræddersyet til at imødekomme dine behov og udfordringer. Udover vores avancerede produktudbud tilbyder vi også et omfattende udvalg af forbrugsvarer, analysestandarder, diagnostiske reagenskits og cutting-edge dataadministrations- og softwareløsninger. Med vores fokus på præcision, pålidelighed og innovation er Shimadzu Danmark din komplette partner inden for analytisk instrumentering. Træd ind i fremtidens laboratorieudstyr med Shimadzu Danmark - hvor videnskab og teknologi forenes for at skabe en bedre og mere effektiv verden. Velkommen til en verden af muligheder og eminent ekspertise hos Shimadzu Danmark!
11 to 50 staff
Draupnir Bio
Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – 40% of the human proteome – untouched. At Draupnir, we are extending the potential of TPD to both extracellular and membrane-bound proteins in a pioneering approach using our novel and differentiated, proprietary technology platform which targets lysosome receptors and has the potential to revolutionise the field of TPD. Led by a highly experienced team of pharma and biotech industry leaders, Draupnir is a spin-out from Aarhus University, Denmark and the Max-Planck Society, Germany and is backed by a syndicate of leading European investors.
11 to 50 staff
Evodiabio
EvodiaBio is a bio-industrial company producing sustainable, natural aromas for the food and beverage industry. Our disruptive yeast-based technology enables consumers to enjoy the benefits of non-alcoholic beer without having to compromise on taste.
11 to 50 staff
Flow Robotics
Flow Robotics A/S is a robotics company with a vision of helping labs across the world transition from manual to automated pipetting. The company makes liquid handling automation accessible to all by breaking down technology barriers with the intuitive and user-friendly robot, flowbot® ONE. With flowbot® ONE there is no need for advanced programming, extensive training or a long implementation period. The pipetting robot can integrate to devices positioned on the deck or externally to the system.
11 to 50 staff
Fuse Vectors
At Fuse Vectors, our mission is to revolutionize AAV gene therapy development. Traditional cell-based technologies have hindered progress, posing challenges in safety, efficacy, development time, and cost. Our Cell-Free AAV technology surpasses these methods, producing safer, more effective, and cost-efficient AAV viral vectors in a fraction of the time.
1 to 10 staff
Roche Danmark
Velkommen til Roche Danmarks LinkedIn profil. En sundere fremtid. Det er vores motivation. Derfor har vi engageret os i danskernes sundhed gennem samarbejde med aktørerne i det danske sundhedsvæsen i mere end 50 år. Med fokus på samlede forløb tilbyder vi digitale sundhedsløsninger med datadrevne teknologier og indsigter, der knytter tidlige diagnoser til målrettede behandlinger af alle sygdomme. Vores tilstedeværelse herhjemme er udbredt gennem flere led i værdikæden. Vi indgår ligeledes i partnerskaber på tværs af sundhedssektoren, fordi vi tror på, at de bedste løsninger og behandlinger for patienterne opnås gennem samskabelse mellem aktørerne. Fra vores kontor i Carlsberg Byen og decentralt placerede kolleger samarbejder vi med partnere, hospitaler, laboratorier, klinikere og patienter over hele landet for at skabe de bedste løsninger og behandlingsforløb for patienterne. Roche Danmarks tre juridiske enheder - Roche Pharmaceuticals A/S, Roche Diagnostics A/S og Roche Diabetes Care - er de danske datterselskaber af F. Hoffmann-La Roche koncernen, der er globalt førende inden for diagnostik og lægemidler. Med et budget på 109 milliarder kroner er vi ligeledes den sundhedsvirksomhed i verden, der investerer mest i forskning og udvikling. Og dermed vejen til en sundere fremtid for alle.
201 to 500 staff
Beyond Leather Materials Aps
At Beyond Leather we are on a mission to Make Waste Beautiful. We take the overlooked resource, apple waste, from the juice and cider producers and transform it into Leap. A premium, vegan-certified leather alternative with 91% USDA certified bio-based content. Soft. Durable. Suitable for small leather goods and furniture. Designed to cause less harm. And the best part? Leap is commercially available now - visit our website.
1 to 10 staff
Bionordika Denmark A S
BioNordika Denmark A/S offers a wide and unique selection of products and services within the areas of Cell- and Molecular Biology - and we only represent the very best suppliers in this field. Our extensive knowledge about advanced life science applications gives us the opportunity to guide you to the right products for your research- PCR/qPCR - NGS library prep - Restriction enzymes - Cloning - Electrophoresis - Antibodies - Primary cells and cell culture media - FISH probes - Endotoxin detection - Assay kits for biomedical research - Molecular diagnostics - Custom services We are a part of AddLife, a company listed on Nasdaq Stockholm. BioNordika are also represented in Sweden, Norway, Finland, and Baltics.
11 to 50 staff
Biotech Research & Innovation Centre Bric , University Of Copenhagen
Biotech Research & Innovation Centre (BRIC) was established in 2003 by the Danish Ministry of Science, Technology and Innovation. Today BRIC is a centre of excellence for biomedical research. The scientists in the centre focus on understanding the molecular mechanisms leading to various diseases, including cancer, CNS-related diseases and metabolic diseases. Our aims are to- perform interdisciplinary, cutting-edge research - establish a strong research education programme - attract funding and new research projects - ensure that research results are used for the development of commercial products - promote exchange of ideas within the Danish biotech research community
51 to 200 staff
Cysbio
Cysbio uses advanced metabolic engineering and synthetic biology approaches to construct bacterial cell factories for transforming the production of biochemicals from renewable feedstocks.
11 to 50 staff
Io Biotech
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field and a world-class advisory board.
51 to 200 staff
Kem-En-Tec Nordic A S
Kem-En-Tec Nordic is a niche lab supplier devoted to helping BioScience lab technicians enhance the quality of their work, whether it is in Pharma & Biotech, on Universities, or Hospitals. We proudly represent a platform of products from more than 100 companies in the field of Protein Technology, Molecular Biology, Cellular Biology, Diagnostics, and Environmental studies. Combined with our 30+ years of market knowledge, we will help you find almost any reagent or kit you need. At Kem-En-Tec we help you to do better, faster, more cost-efficient, and sustainable in your research and diagnostics with innovation and uniqueness. We aim to be your top service partner, and our highly trained scientific staff takes great pride in knowing that you will quickly receive a qualified reply to any inquiry. Please do not hesitate to contact us - we love to help you in your research process. Kem-En-Tec Nordic A/S - Competent Bioscience since 1987
11 to 50 staff
Tebubio
We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster- We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance- We accelerate their Research thanks to our Contract Research Services’ strong expertise in mRNA production & delivery, cell line engineering & protein production, cellular studies and biomarkers analysis when they lack time, routine practice or expertise- We streamline their ordering process thanks to our e-procurement solutions, enable them to benefit from our many years of supply chain experience in handling biological solutions, save significant time and avoid administrative complexity as they can rely on the permits and certifications we hold. With Tebubio, concentrate your efforts and accelerate what’s most important to you: Your Research.
51 to 200 staff
